2020 & 2022 GLOBAL FINALIST

Amai Proteins

Agtech Covid-19

Sugar overconsumption underlies the Metabolic Syndrome (obesity, diabetes, cancers and more), a global health challenge affecting the lower socioeconomic classes the most. It is a burden on arable land, water usage, and contamination of air, land and sea. Amai (‘sweet’ in Japanese) produces the first healthy, tasty, and market-fit sweetener via Amai’s Pro-Protein Platform: Pro-Design AI-CPD (Computational Protein Design), Pro-Planet precision fermentation and Pro-Taste food technology. Next, Amai targets meat, milk and plant applications.

💸 Select investors: SGInnovate, K3 Ventures, iAngels, Zora impact fund, Welltech Ventures Wellness Fund, BayWa, Sucden, Japan-Israel Hitech Ventures, Dragones (Argentina), Aston Partners, Olympic Investments

📌 HQ: Rehovot, HaMerkaz, Israel

🔗 https://www.amaiproteins.com/